Comments
Loading...

Exelixis

EXELNASDAQ
Logo brought to you by Benzinga Data
$35.61
0.782.24%
At close: -
$35.75
0.140.39%
After Hours: Nov 22, 7:30 PM EDT
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

Exelixis (NASDAQ:EXEL) Stock Quotes, Forecast and News Summary

Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.

20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jul
2
Aug
2
1
Sep
10
2
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$34.83
Close$35.61
Volume / Avg.1.76M / 2.05M
Day Range$34.76 - $35.69
52 Wk Range19.20 - 36.60
Market Cap$10.21B
P/E Ratio22.47
Dividend Yield-
ExchangeNASDAQ
RSI
73
Short Interest
4.3%
Days to Cover3.44

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EXEL
SRPT

FAQ

Q

How do I buy Exelixis (EXEL) stock?

A

You can purchase shares of Exelixis (NASDAQ:EXEL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Exelixis (EXEL) competitors?

Q

What is the forecast, or price target, for Exelixis (EXEL) stock?

A

Exelixis has a consensus price target of $30.80.

Q

What is the current price for Exelixis (EXEL)?

A

The stock price for Exelixis (NASDAQ: EXEL) is $35.7499 last updated November 22, 2024 at 7:30 PM EST.

Q

Does Exelixis (EXEL) pay a dividend?

A

There are no upcoming dividends for Exelixis.

Q

When is Exelixis (NASDAQ:EXEL) reporting earnings?

A

Exelixis’s Q4 earnings are confirmed for Tuesday, February 4, 2025.

Q

Is Exelixis (EXEL) going to split?

A

There is no upcoming split for Exelixis.

Q

What sector and industry does Exelixis (EXEL) operate in?

A

Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch